Skip to main content

Atea Pharmaceuticals, Inc 8-K, filed Nov 9, 2026

Atea Pharmaceuticals, Inc. (AVIR)

8-K 2026-11-09 For: 2026-11-09
View Original
Added on November 09, 2026

About this 8-K

Atea Pharmaceuticals, Inc filed this 8-K on November 9, 2026.

Atea Pharmaceuticals reported that BEM/RZR met primary and secondary endpoints in Phase 3 C-BEYOND, secured a Hercules Capital credit facility for up to $200 million, and had $191.2 million in cash and investments, with current resources expected to fund operations into mid-2028. AI summary

Items reported

  • Item 2.02: Financial results
  • Item 9.01: Financial statements and exhibits